↓ Skip to main content

Histamine targets myeloid-derived suppressor cells and improves the anti-tumor efficacy of PD-1/PD-L1 checkpoint blockade

Overview of attention for article published in Cancer Immunology, Immunotherapy, October 2018
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (72nd percentile)
  • Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

twitter
7 X users
patent
1 patent
facebook
1 Facebook page

Citations

dimensions_citation
59 Dimensions

Readers on

mendeley
59 Mendeley
Title
Histamine targets myeloid-derived suppressor cells and improves the anti-tumor efficacy of PD-1/PD-L1 checkpoint blockade
Published in
Cancer Immunology, Immunotherapy, October 2018
DOI 10.1007/s00262-018-2253-6
Pubmed ID
Authors

Hanna Grauers Wiktorin, Malin S. Nilsson, Roberta Kiffin, Frida Ewald Sander, Brianna Lenox, Anna Rydström, Kristoffer Hellstrand, Anna Martner

X Demographics

X Demographics

The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 59 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 59 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 10 17%
Student > Master 9 15%
Student > Doctoral Student 6 10%
Researcher 5 8%
Student > Ph. D. Student 5 8%
Other 7 12%
Unknown 17 29%
Readers by discipline Count As %
Medicine and Dentistry 14 24%
Biochemistry, Genetics and Molecular Biology 12 20%
Immunology and Microbiology 5 8%
Agricultural and Biological Sciences 3 5%
Engineering 2 3%
Other 3 5%
Unknown 20 34%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 February 2023.
All research outputs
#5,111,832
of 24,793,937 outputs
Outputs from Cancer Immunology, Immunotherapy
#508
of 2,943 outputs
Outputs of similar age
#94,779
of 352,703 outputs
Outputs of similar age from Cancer Immunology, Immunotherapy
#7
of 26 outputs
Altmetric has tracked 24,793,937 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,943 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one has done well, scoring higher than 82% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 352,703 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.
We're also able to compare this research output to 26 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.